Islet amyloid in recent-onset type 1 diabetes—the DiViD study

Gunilla T.  Westermark; Lars  Krogvold; Knut  Dahl-Jørgensen; Johnny  Ludvigsson

doi:10.1080/03009734.2017.1359219

Islet amyloid in recent-onset type 1 diabetes—the DiViD study

Gunilla T. Westermark Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Lars Krogvold Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; and Faculty of Medicine, University of Oslo, Oslo, Norway
Knut Dahl-Jørgensen Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; and Faculty of Medicine, University of Oslo, Oslo, Norway
Johnny Ludvigsson Department of Clinical and Experimental Medicine, Division of Pediatrics and Diabetes Research Centre, Linköping University Hospital, Linköping, Sweden

DOI: https://doi.org/10.1080/03009734.2017.1359219

Downloads

Download data is not yet available.

Download PDF

Published

2017-08-17

How to Cite

Westermark G. T., Krogvold L., Dahl-Jørgensen K., & Ludvigsson J. (2017). Islet amyloid in recent-onset type 1 diabetes—the DiViD study. Upsala Journal of Medical Sciences, 122(3), 201–203. https://doi.org/10.1080/03009734.2017.1359219

Download Citation

Issue

Vol. 122 No. 3 (2017): Upsala J Med Sci

Section

Letters to the Editor

Authors retain copyright of their work, with first publication rights granted to Upsala Medical Society. Read the full Copyright- and Licensing Statement.

Islet amyloid in recent-onset type 1 diabetes—the DiViD study

Downloads

Most read articles by the same author(s)